119 related articles for article (PubMed ID: 37150501)
1. Acyl-CoA thioesterase 12 suppresses YAP-mediated hepatocarcinogenesis by limiting glycerolipid biosynthesis.
He H; Sugiyama A; Snyder NW; Teneche MG; Liu X; Maner-Smith KM; Goessling W; Hagen SJ; Ortlund EA; Najafi-Shoushtari SH; Acuña M; Cohen DE
Cancer Lett; 2023 Jul; 565():216210. PubMed ID: 37150501
[TBL] [Abstract][Full Text] [Related]
2. Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis.
Wang H; Wang J; Zhang S; Jia J; Liu X; Zhang J; Wang P; Song X; Che L; Liu K; Ribback S; Cigliano A; Evert M; Wu H; Calvisi DF; Zeng Y; Chen X
Cell Mol Gastroenterol Hepatol; 2021; 11(4):1095-1117. PubMed ID: 33232824
[TBL] [Abstract][Full Text] [Related]
3. ACOT12-Dependent Alteration of Acetyl-CoA Drives Hepatocellular Carcinoma Metastasis by Epigenetic Induction of Epithelial-Mesenchymal Transition.
Lu M; Zhu WW; Wang X; Tang JJ; Zhang KL; Yu GY; Shao WQ; Lin ZF; Wang SH; Lu L; Zhou J; Wang LX; Jia HL; Dong QZ; Chen JH; Lu JQ; Qin LX
Cell Metab; 2019 Apr; 29(4):886-900.e5. PubMed ID: 30661930
[TBL] [Abstract][Full Text] [Related]
4. Enzymatic and transcriptional regulation of the cytoplasmic acetyl-CoA hydrolase ACOT12.
Horibata Y; Ando H; Itoh M; Sugimoto H
J Lipid Res; 2013 Aug; 54(8):2049-2059. PubMed ID: 23709691
[TBL] [Abstract][Full Text] [Related]
5. Evodiamine inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells via the Hippo-Yes-Associated Protein signaling pathway.
Zhao S; Xu K; Jiang R; Li DY; Guo XX; Zhou P; Tang JF; Li LS; Zeng D; Hu L; Ran JH; Li J; Chen DL
Life Sci; 2020 Jun; 251():117424. PubMed ID: 32057900
[TBL] [Abstract][Full Text] [Related]
6. TAZ is indispensable for c-MYC-induced hepatocarcinogenesis.
Wang H; Zhang S; Zhang Y; Jia J; Wang J; Liu X; Zhang J; Song X; Ribback S; Cigliano A; Evert M; Liang B; Wu H; Calvisi DF; Zeng Y; Chen X
J Hepatol; 2022 Jan; 76(1):123-134. PubMed ID: 34464659
[TBL] [Abstract][Full Text] [Related]
7. Loss of SPTBN1 Suppresses Autophagy Via SETD7-mediated YAP Methylation in Hepatocellular Carcinoma Initiation and Development.
Chen S; Wu H; Wang Z; Jia M; Guo J; Jin J; Li X; Meng D; Lin L; He AR; Zhou P; Zhi X
Cell Mol Gastroenterol Hepatol; 2022; 13(3):949-973.e7. PubMed ID: 34737104
[TBL] [Abstract][Full Text] [Related]
8. Bortezomib inhibits hepatocellular carcinoma via the Hippo-Yes-associated protein signalling pathway.
Liao Y; Hu K; Liu W; Wang W; Qiu H; Pan S; Lv Q; Xu G
Basic Clin Pharmacol Toxicol; 2023 Apr; 132(4):297-311. PubMed ID: 36585038
[TBL] [Abstract][Full Text] [Related]
9. The Clinicopathological Significance of YAP/TAZ Expression in Hepatocellular Carcinoma with Relation to Hypoxia and Stemness.
Park H; Lee Y; Lee K; Lee H; Yoo JE; Ahn S; Park YN; Kim H
Pathol Oncol Res; 2021; 27():604600. PubMed ID: 34257565
[No Abstract] [Full Text] [Related]
10. ACOT12-mediated acetyl-CoA hydrolysis suppresses intrahepatic cholangiocarcinoma metastasis by inhibiting epithelial-mesenchymal transition.
Zhou X; Zhou Y; Shao W; Hong L; Lu M; Zhu W
J Cancer; 2022; 13(6):1734-1744. PubMed ID: 35399720
[TBL] [Abstract][Full Text] [Related]
11. Ablation of high-mobility group box-1 in the liver reduces hepatocellular carcinoma but causes hyperbilirubinemia in Hippo signaling-deficient mice.
Athavale D; Song Z; Desert R; Han H; Das S; Ge X; Komakula SSB; Chen W; Gao S; Lantvit D; Guzman G; Nieto N
Hepatol Commun; 2022 Aug; 6(8):2155-2169. PubMed ID: 35344292
[TBL] [Abstract][Full Text] [Related]
12. Yes-associated protein/TEA domain family member and hepatocyte nuclear factor 4-alpha (HNF4α) repress reciprocally to regulate hepatocarcinogenesis in rats and mice.
Cai WY; Lin LY; Hao H; Zhang SM; Ma F; Hong XX; Zhang H; Liu QF; Ye GD; Sun GB; Liu YJ; Li SN; Xie YY; Cai JC; Li BA
Hepatology; 2017 Apr; 65(4):1206-1221. PubMed ID: 27809333
[TBL] [Abstract][Full Text] [Related]
13. Yes-associated protein (YAP) induces a secretome phenotype and transcriptionally regulates plasminogen activator Inhibitor-1 (PAI-1) expression in hepatocarcinogenesis.
Marquard S; Thomann S; Weiler SME; Bissinger M; Lutz T; Sticht C; Tóth M; de la Torre C; Gretz N; Straub BK; Marquardt J; Schirmacher P; Breuhahn K
Cell Commun Signal; 2020 Oct; 18(1):166. PubMed ID: 33097058
[TBL] [Abstract][Full Text] [Related]
14. Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer.
Weiler SME; Pinna F; Wolf T; Lutz T; Geldiyev A; Sticht C; Knaub M; Thomann S; Bissinger M; Wan S; Rössler S; Becker D; Gretz N; Lang H; Bergmann F; Ustiyan V; Kalin TV; Singer S; Lee JS; Marquardt JU; Schirmacher P; Kalinichenko VV; Breuhahn K
Gastroenterology; 2017 Jun; 152(8):2037-2051.e22. PubMed ID: 28249813
[TBL] [Abstract][Full Text] [Related]
15. RASSF1A-mediated regulation of AREG via the Hippo pathway in hepatocellular carcinoma.
Ahn EY; Kim JS; Kim GJ; Park YN
Mol Cancer Res; 2013 Jul; 11(7):748-58. PubMed ID: 23594797
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter arterial chemoembolization combined with Hippo/YAP inhibition significantly improve the survival of rats with transplanted hepatocellular carcinoma.
Quan Y; Li Z; Zhu K; Liang J
Lipids Health Dis; 2021 Jul; 20(1):74. PubMed ID: 34304741
[TBL] [Abstract][Full Text] [Related]
17. Retinal dehydrogenase 5 (RHD5) attenuates metastasis via regulating HIPPO/YAP signaling pathway in Hepatocellular Carcinoma.
Hu H; Xu L; Luo SJ; Xiang T; Chen Y; Cao ZR; Zhang YJ; Mo Z; Wang Y; Meng DF; Yu L; Lin LZ; Zhang SJ
Int J Med Sci; 2020; 17(13):1897-1908. PubMed ID: 32788868
[TBL] [Abstract][Full Text] [Related]
18. Complex roles of Hippo-YAP/TAZ signaling in hepatocellular carcinoma.
Shi H; Zou Y; Zhong W; Li Z; Wang X; Yin Y; Li D; Liu Y; Li M
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15311-15322. PubMed ID: 37608027
[TBL] [Abstract][Full Text] [Related]
19. Loss of Acot12 contributes to NAFLD independent of lipolysis of adipose tissue.
Park S; Song J; Baek IJ; Jang KY; Han CY; Jun DW; Kim PK; Raught B; Jin EJ
Exp Mol Med; 2021 Jul; 53(7):1159-1169. PubMed ID: 34285335
[TBL] [Abstract][Full Text] [Related]
20. Deregulation of Hippo kinase signalling in human hepatic malignancies.
Li H; Wolfe A; Septer S; Edwards G; Zhong X; Abdulkarim AB; Ranganathan S; Apte U
Liver Int; 2012 Jan; 32(1):38-47. PubMed ID: 22098159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]